Use access key #2 to skip to page content.
$0.46 -0.04 (-8.04%)
11/21/2008 3:58 PM

Candela Corp (CLZR)

CAPS Rating:
*

The Company is engaged in the development and commercialization of aesthetic laser systems that allow physicians and personal care practitioners to treat a variety of cosmetic and medical conditions.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

CLZR doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

36 Outperforms
22 Underperforms
 

All-Stars

8 Outperforms
8 Underperforms
 

Wall Street

2 Outperforms
1 Underperforms
 

Members bullish on CLZR are also bullish on:

Members bearish on CLZR are also bearish on:

Ticker Tags

Healthcare Equipment and Supplies (183), Equipment (55), Medical Lasers (5), Micro Cap (5043)
Suggest a tag

Candela Corp At A Glance

Current Price: $0.46
Last Trade Time: 11/21/2008 3:58 PM
Open: $0.50
Previous Close: $0.50
Daily Range: $0.46 - $0.59
52-Week Range: $0.31 - $6.54
Volume: 61,072
Market Cap: $11.43M
P/E Ratio: 46.44
Compare Our Special Broker Offers!

Stock Trends

CLZR VS S&P 500 (SPY)

News & Discussion Boards

More Fool Articles...

Top Bull Pitch

Recs

1

Candela Corp (CLZR)

Avatar ratrop1 (< 20) Submitted: 9/25/07 2:11 PM

Candela has been in a long slide that may finally be ending. At their most recent investor presentation they seemed (finally!) to be on the cusp of multiple new product inttroductions, which they've grossly underperformed on historically. They also have $50 million of cash (equates to $2.00 of their...More

Replies: 1 | Reply | Permalink

Top Bear Pitch

Recs

3

Candela Corp (CLZR)

Avatar fraser24gt (83.03) Submitted: 9/22/06 7:24 AM

The CEO is a habitual liar, which is never a good thing. They do the same thing that Palomar does, except Palomar does it better. All you have to do is look at EPS growth for the pas few quarters and you will see why Candela is going down.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 9 :   1 2 Next »

Show Pitch Replies

Recs

0

 (CLZR)

Avatar dmoore1848 (< 20) Submitted: 10/23/07 2:31 PM : Underperform Start Price: $7.34 CLZR Score: 43.88

The technology is stale, company has nothing new and exciting.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (CLZR)

Avatar ratrop1 (< 20) Submitted: 9/25/07 2:11 PM : Outperform Start Price: $7.99 CLZR Score: -44.40

Candela has been in a long slide that may finally be ending. At their most recent investor presentation they seemed (finally!) to be on the cusp of multiple new product inttroductions, which they've grossly underperformed on historically. They also have $50 million of cash (equates to $2.00 of their stock price) and no debt, the largest market share in the laser market, and a global sales network. They've announced an increased stock buyback plan equal to 10% of shares outstanding. And they are "in play" by a Canadian activist investor and JP Morgan, who together have accumulated around 23% of the stock (at a basis much higher than today's stock price). So it seems to me that Candela will either get their own act together soon, or be forced to do so by investors. A wild card is their ongoing patent lawsuit with Palomar, but that seems already reflected in the stock price. I'm buying...

Report this Post Replies: 1 | Reply | Permalink

Recs

0

 (CLZR)

Avatar TheBarnacle (82.81) Submitted: 8/29/07 9:07 AM : Outperform Start Price: $7.79 CLZR Score: -46.62

Price Target of 14.90

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CLZR)

Avatar IPProfiler (< 20) Submitted: 4/09/07 5:30 PM : Outperform Start Price: $10.85 CLZR Score: -48.30

CLZR was sued by PMTI on a hair removal patent that has not been tested in court. Both sides have deep pockets & good attys. CLZR's patent suit in ED Texas (wrinkle removal) will go to trial first, Sept 2008. These 2 cases could eat up $2-3 million in fess per side in fees & expenses, IF, they do not go to war. CLZR has a good defense to PMTI's claim but the risk loosing can not be ignored.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CLZR)

Avatar EBLou (33.44) Submitted: 1/20/07 12:29 PM : Underperform Start Price: $12.50 CLZR Score: 49.32

Stock will continue to struggle until the patent issues are put behind it

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 9 :   1 2 Next »

Wall Street

Results 1 - 3 of 3  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackSoros < 20 09/30/07 Outperform NS $8.49-94.58%-50.30%-44.28 Toggle the visibility of 60-Second Pitch and replies
TrackJimCramer 85.65 10/27/06 Underperform 3W $14.35-96.79%-44.83%+51.96
TrackMatrix 90.83 08/24/06 Outperform NS $10.32-95.54%-41.70%-53.84

Results 1 - 3 of 3  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links